LEADER 02927oam  2200445zu 450 
001 9910876605903321
005 20210807003037.0
010   $a3-527-62086-9
035   $a(CKB)1000000000687481
035   $a(SSID)ssj0000388113
035   $a(PQKBManifestationID)12154469
035   $a(PQKBTitleCode)TC0000388113
035   $a(PQKBWorkID)10430969
035   $a(PQKB)11605829
035   $a(NjHacI)991000000000687481
035   $a(EXLCZ)991000000000687481
100   $a20160829d1999      uy 
101 0 $aeng
135   $aur|||||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5
210 31$a[Place of publication not identified]$cWiley VCH Imprint$d1999
215   $a1 online resource (xvi, 562 pages) $cillustrations
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a3-527-28315-3 
327   $aTypes and Function of Proteins -- Sequence and Structure of Proteins -- Protein Interactions -- In vitro Folding of Inclusion Body Proteins on an Industrial Scale -- Medical Applications of Recombinant Proteins in Humans and Animals -- Enzymes for Industrial Applications -- Antibody Engineering and Expression -- Manufacture of Therapeutic Antibodies -- Use of Antibodies for Immunopurification -- Preclinical Testing of Antibodies: Pharmacology, Kinetics and Immunogenicity -- Preclinical Testing of Antibodies : Safety Aspects -- Therapeutic Applications of Monoclonal Antibodies : A Clinical Overview -- Antibodies for Sepsis: Some Lessons Learnt -- An Engineered Human Antibody for Chronic Therapy : CDP571 -- Antibody Targeted Chemotherapy -- ReoPro Clinical Development : A Case Study -- Overview of Gene Therapy -- Viral Vectors for Gene Therapy -- Non-Viral Vectors for Gene Therapy -- Issues of Large-Scale Plasmid DNA Manufacturing -- Gene Therapy for HIV Infection -- Regulation of Antibodies and Recombinant Proteins -- Regulation of Human Gene Therapy -- Economic Considerations.
330   $aIn the field of medicinal biotechnology three major developments have caused a revolution in research that has a lot of innovative effects on clinical medicine and future applications on humans. With the availability of tailored recombinant proteins and the opportunity to produce high amounts of monoclonal antibodies new diagnostic applications have emerged and many therapeutic perspectives, e.g. in the treatment of multiple sclerosis and of cancer, are being discussed today.
606   $aBiotechnology
615  0$aBiotechnology.
676   $a660.6
700   $aMountain$b A$01761069
702   $aSchomburg$b Dietmar
702   $aNey$b U. M
801  0$bPQKB
906   $aBOOK
912   $a9910876605903321
996   $aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5$94200270
997   $aUNINA